Patient Guide

Guide to Autoimmune Blood Tests

Autoimmune diseases are diagnosed with a panel of specific blood tests. Each test targets different antibodies. This guide explains which test detects which disease.

Autoimmune blood tests and what they detect

TestPrimary diseaseSensitivity
ANA (antinuclear antibody)Lupus (SLE) — screening test95% in SLE
Anti-dsDNALupus — specific, tracks disease activity70% in SLE
Anti-SmLupus — highly specific25% in SLE
Anti-Ro (SSA) / Anti-La (SSB)Sjögren's syndrome, neonatal lupus~75% in Sjögren's
Rheumatoid Factor (RF)Rheumatoid arthritis (RA)70–80% in RA
Anti-CCPRheumatoid arthritis — more specific than RF70–80% in RA, >99% specific
Anti-Scl-70 (anti-topoisomerase)Diffuse cutaneous scleroderma~40% in scleroderma
Anti-centromereLimited scleroderma (CREST syndrome)~80% in limited scleroderma
ANCA (PR3 / MPO)Vasculitis (GPA, MPA)~90% in active GPA
Anti-Jo-1Polymyositis / dermatomyositis~25% in IIM
Complement C3 & C4Low in lupus flares, hereditary complement deficiencyTrack disease activity

ANA — the starting point

Why ANA is ordered first

ANA is ordered as the first screening test when an autoimmune condition is suspected. A positive ANA at titre ≥1:80 prompts further specific antibody tests to identify the exact disease. A negative ANA makes most ANA-associated diseases (lupus, Sjögren's, scleroderma) very unlikely. However, some autoimmune diseases are ANA-negative — notably RA, ANCA vasculitis, and anti-Jo-1 myositis.

Complement levels in autoimmune disease

Complement proteins (C3 and C4) are part of the immune system. In lupus, immune complexes consume complement, causing low C3 and C4 — especially during flares. Low complement with high anti-dsDNA is a reliable indicator of lupus disease activity and kidney involvement. Complement is normal or raised in RA and most other autoimmune conditions.

Questions to ask your rheumatologist

Medical Disclaimer: For educational purposes only. Always consult a qualified healthcare professional for diagnosis and treatment.